Friday, May 1, 2026

“MY SLAVES MY RULES” Pyonyang’s Sickening Claim That Human Rights Violate Their So Called Sovereignty

North Korea criticizes UN human rights resolution as a violation of sovereignty, calling it a political attack and warning of repercussions.

LG Innotek Targets Flawless AI Vision with Intel-Powered Upgrade

LG Innotek partners with Intel to enhance AI vision inspection, aiming for nearly 100% accuracy in manufacturing processes.

16-Year Old’s Fate in Balance After Attack on Rep. Bae Hyun Jin

A South Korean court will announce the verdict for a student charged with attacking Rep. Bae Hyun Jin, focusing on mental capacity claims.

Tag: Patent

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SCL Healthcare secures patent for technology predicting metabolic syndrome using 3cc of blood

SCL Healthcare has patented a DNA methylation technology to predict metabolic syndrome risk, enhancing disease diagnosis from blood samples.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.